Dr. Elliot Smith
Chief Executive Officer
Dr. Elliot Smith is one of the leading voices of Artificial Intelligence for healthcare in the world. After completing his PhD at the University of Queensland - Elliot founded Maxwell Plus after seeing huge issues with the rates of early and accurate detection. He has published numerous papers across the use of Artificial Intelligence in healthcare and is the supervisor of a number of PhD students studying Artificial Intelligence applications to imaging of the brain and body.
Dr. Peter Swindle
Chief Medical Officer
Dr. Peter Swindle is one of Australia's leading Urologists having worked solely in prostate cancer for many years. He has treated thousands of patients and conducted thousands of robotic prostatectomys across the country. Dr. Swindle is passionate about early and accurate detection and has been heavily involved in the advocacy of early testing and the use of multi-parametric MRI.
Phil is a Partner at the CSIRO's venture capital fund - Main Sequence Ventures. He invests in deep tech founders who are building unimaginable new companies with a strong connection to research. Before this, he was the founder of Australia’s first Silicon Valley-style incubator, Pollenizer, where Phil played an instrumental role in developing the startup ecosystem across the Asia Pacific and advised some of the world’s biggest organisations on practical ways to deliver new growth and the cultural change that is required to get there.
Chief Operations Officer
Tom is responsible for ensuring Maxwell Plus' patients get the accurate, fast and high-quality care they need. Before Maxwell Plus - Tom was an engineer and management consultant with McKinsey & Company gaining experience across a number of industries in strategic development, operations improvements and transaction advisory. He was a co-founder of a medical device startup at University that successfully completed a number of medical trials.
Maxwell Plus is entered in the ARTG, ARTG no. 315627
TÜV SÜD no. G1 004507 0002 Rev. 00
TÜV SÜD no. Q5 004507 0001 Rev. 00